Skip to main content

DESARROLLO DE NANOMEDICINAS PARA TERAPIAS ANTITUMORALES E INMUNOSUPRESORAS

SAF2014-54057-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Analysis of the intra-lysosomal degradative interactome of magnetic nanoparticles

  • Portilla, Yadileiny
  • Sanz-Ortega, Laura
  • Pérez-Yagüe, Sonia
  • Paradela, Alberto
  • Morales, María Del Puerto
  • Barber, Domingo F.
Poster presented at the Nanomaterials Applied to Life Sciences (NALS), held in Gijón (Spain) on December 13-15th, 2017., Superparamagnetic iron oxide nanoparticles (SPIONs) have a great potential in the field of biomedicine due to its size and physical properties. Some examples would be the targeted drug release, the therapeutic hyperthermia and magnetic resonance imaging. The achieved success in lab assays using SPIONs led us to think that a fast transition to the clinic practice would occur, however this progress was slowed down by the lack of information regarding the molecular and cellular mechanisms that regulate the degradation of the nanoparticles, since it could affect the therapeutic efficiency of the SPIONs or its accumulation and toxicity on the long term. Once the SPIONs enter the body intravenously, they accumulate mostly in the liver and the spleen, where they are captured by macrophages of the reticuloendothelial system (1,2). SPIONs are all superparamagnetic but as time passes they gradually lose this magnetism, which suggests that the lysosome degrades SPIONs (2). Several studies, including those from our research group, have shown that after a period of time, these SPIONs are completely degraded. Such disposal processes point to a specific iron transformation metabolism in the lysosomes, which might be part of the cell¿s physiological iron degradation pathway or might imply the existence of another degenerative process in the cell interactome. To analyze this process and the proteins of the lysosome involved is the main goal of our ongoing research. The first step to achieve this objective is to isolate the organelles where the degradative process takes place: obtain the intra-lysosomal degradative interactome of the SPIONs. To achieve this, a magnetic isolation method was used. To corroborate that the obtained cellular fraction was rich on SPION loaded lysosomes, several techniques were performed: Western blot, microscopy (confocal, fluorescence and TEM) and mass spectrometry analysis. Western blot experiments showed that the sample was rich in LAMP 1 protein, which is typically found in the lysosome membrane, which confirmed that lysosomes were clearly present. Once obtained, we tested its integrity via microscopy. In fluorescence and confocal microscopy, the areas in which SPION appeared were surrounded by lysosomes. In a subsequent analysis by TEM, we observed full lysosomes. This cell fraction was then used for proteomic analysis. It allowed us to obtain a first approximation for the description of the cellular interactome induced by treatment with SPIONs. In this experiment we validate the enrichment of the lysosomal fraction and identify possible proteins involved in the degradation of the nanoparticles. So far, a SPION-rich lysosome fraction has been isolated, which allow us to further study the process of degradation over time of the SPIONs and the proteins involved in it. This knowledge will contribute to make the use of the SPIONs on the clinical practice a reality and to develop a more efficient second generation of nanoparticles., This work was supported by an FPU grant (FPU15/06170) to YP and a Spanish Ministry of Economy and Competitiveness/FEDER grant (MINECO SAF-2014-54057-R) to DFB.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Understanding magnetic hyperthermia

  • Hernández Flores, Patricia
  • Talelli, Marina
  • Barber, Domingo F.
Poster presented at the Nanomaterials Applied to Life Sciences (NALS), held in Gijón (Spain) on December 13-15th, 2017., Magnetic hyperthermia (MH) is the selective temperature increase in tumour tissues preloaded with magnetic nanoparticles (MNP) able to release heat in response to application of an alternating magnetic field (AMF) in the radiofrequency range. Despite much research, the underlying mechanism as to how this treatment causes cell death remains unclear. To test whether the biological effects mediated by MNP under an AMF were caused by heat dissipation originated from MNP, we performed in vitro MH experiments using (3-aminopropyl)-triethoxysilane-coated MNP (APS-MNP) with different core sizes (6, 8 and 14 nm). Suspended in water, these MNP produce increasing amounts of heat in the presence of an AMF (30 mT maximum, 250 kHz). After characterizing the MNP, we studied cell viability and particle uptake by murine pancreatic adenocarcinoma Pan02 cells. We measured cytotoxicity using a colorimetric PrestoBlue assay, quantified intracellular MNP amounts by ICP-OES (inductively coupled plasma atomic emission spectroscopy), and visualized the MNP by TEM (transmission electron microscopy). In addition, we used the PrestoBlue assay to test the effect of MH treatment on cell viability. To complement these results, we analysed activation of the effector caspase-3 by Western blot, and studied changes in cell morphology by TEM. After AMF exposure, cell viability was reduced. TEM images showed morphological features of apoptosis, which was confirmed by caspase-3 activation. We nonetheless found that all three MNP showed similar results, despite their distinct heat-producing abilities. Comparison of mRNA Hspa1b levels (increased in stress conditions, including heat stress) showed increased expression not only by MNP-loaded cells but also by non-loaded control samples when exposed to AMF. Cells thus received heat from an external source, the copper coil that generated the AMF and was heated due to passage of the electric current. To resolve this difficulty, experimental settings were modified and MH experiments repeated, maintaining the culture medium temperature at 37 ºC throughout AMF application, thus excluding the effect of the heat generated by the coil. In the conditions of these new experimental settings, we found none of the previously observed effects, in agreement with results described in the literature [1,2]. In conclusion, in our experimental setting MH treatment only appears to have an effect when combined with external heating. Our goal now is to understand our system when applying magnetic hyperthermia under physiological temperature conditions., PHF received a pre-doctoral Severo Ochoa grant from the Department of Research, Development and Innovation, within the Spanish Ministry of Economy and Competitiveness (MINECO). MT received a JdC post-doctoral grant (JCI-2012-13159) from the MINECO. This work was supported by a grant from the MINECO (SAF-2014-54057-R to DFB).